Blog
03-12-2025Cross-posted from: NIAID Newsroom The antiviral drug tecovirimat used without other antivirals did not reduce the time to clinical resolution of clade II mpox…
NIAID Newsroom
Tecovirimat Is Safe but Ineffective as Treatment for Clade II Mpox - Blog
NIH Study Finds Tecovirimat Was Safe but Did Not Improve Mpox Resolution or Pain 12-16-2024Cross-posted from: NIAID Newsroom The antiviral drug tecovirimat did not reduce the time to lesion resolution or have an effect on pain among adults with mild… - Blog
Kidney Transplantation Between Donors and Recipients with HIV Is Safe 10-17-2024Cross-posted from: NIAID Newsroom Kidney transplantation from deceased donors with HIV (HIV D+) to recipients with HIV (HIV R+) was safe and comparable to… - Blog
Exploratory Analysis Associates HIV Drug Abacavir with Elevated Cardiovascular Disease Risk in Large Global Trial 07-26-2024Cross-posted from: NIAID NewsroomCurrent or previous use of the antiretroviral drug (ARV) abacavir was associated with an elevated risk of major adverse… - Blog
Statement: Long-Acting HIV Treatment Demonstrates Efficacy in People with Challenges Taking Daily Medicine as Prescribed 02-22-2024Cross-posted from: NIAID Newsroom Long-acting antiretroviral therapy (ART) with cabotegravir and rilpivirine was superior in suppressing HIV replication… - Blog
NIH Research Identifies Opportunities to Improve Future HIV Vaccine Candidates 12-20-2023Cross-posted from: NIAID Newsroom An effective HIV vaccine may need to prompt strong responses from immune cells called CD8+ T cells to protect people from… - Blog
Clinical Trial of HIV Vaccine Begins in United States and South Africa 09-26-2023Cross-posted from: NIAID newsroomA trial of a preventive HIV vaccine candidate has begun enrollment in the United States and South Africa. The Phase 1 trial… - Blog
Daily Statin Reduces the Risk of Cardiovascular Disease in People Living with HIV, Large NIH Study Finds 04-14-2023Cross-posted from NIAID Newsroom A National Institutes of Health (NIH) clinical trial was stopped early because a daily statin medication was found to reduce… - Blog
Early HIV Diagnosis and Treatment Important for Better Long-term Health Outcomes 11-02-2022Cross-posted from NIAID Newsroom Starting antiretroviral treatment (ART) early in the course of HIV infection when the immune system is stronger results in… - Blog
Clinical Trial Evaluating Monkeypox Vaccine Begins 09-09-2022Cross-posted from NIAID Newsroom NIH Trial is Evaluating Intradermal Delivery to Expand the Vaccine Supply. Interested volunteers can visit clinicaltrials.gov… - Blog
Combination Anti-HIV Antibody Infusions Suppress Virus for Sustained Period 06-02-2022Cross-posted from NIAID Newsroom Strategy May Offer Alternative to Daily Antiretrovirals Individuals with HIV who began taking antiretroviral therapy (ART) in… - Blog
NIH Launches Clinical Trial of Three mRNA HIV Vaccines 03-23-2022Cross-posted from NIAID NewsroomPhase 1 Study Is Among First to Examine mRNA Technology for HIVThe National Institute of Allergy and Infectious Diseases (NIAID… - Blog
Researchers Document Third Known Case of HIV Remission Involving Stem Cell Transplant 02-15-2022Cross-posted from NIAID NewsroomWoman Has Remained Without Detectable HIV for 14 MonthsA woman with HIV who received a cord blood stem cell transplant to treat… - Blog
Experimental mRNA HIV Vaccine Safe, Shows Promise in Animals 12-15-2021Cross-posted from the NIAID NewsroomNIAID Scientists Developed Vaccine PlatformAn experimental HIV vaccine based on mRNA—the same platform technology used in… - Blog
Too Many People with HIV Fail to Achieve Durable Viral Suppression 11-30-2021NIH-Funded Study Estimates Global Progress Toward UNAIDS GoalCross-posted from NIAID NewsroomAmong people with HIV worldwide who are receiving antiretroviral… - Blog
NIH Experts Call for Accelerated Research to Address Concurrent HIV and COVID-19 Pandemics 04-09-2021Cross-posted from NIAID NewsroomThe COVID-19 pandemic is affecting people with or at risk for HIV both indirectly, by interfering with HIV treatment and… - Blog
NIH Announces Restructured HIV Clinical Trials Networks 12-03-2020Cross-posted from NIAID NewsroomGrant Awards Set Stage for Next Seven Years of Science-Driven HIV Clinical ResearchThe National Institute of Allergy and… - Blog
NIAID Observes HIV Vaccine Awareness Day 2020 05-18-2020Cross-posted from NIAID NewsroomDecades of scientific advances have led to development and implementation of highly effective HIV treatment and prevention… - Blog
NIH-Funded AIDS Clinical Trials Group Conducts COVID-19 Treatment Study 05-15-2020Cross-posted from NIAID NewsroomStudy Enrolling Adults with Mild to Moderate COVID-19 in the United States.Adults interested in participating in the trial… - Blog
NIH Study Finds Lower Concentration of PrEP Drug in Pregnant Young Women 03-09-2020Cross-posted from NIAID NewsroomAmong African adolescent girls and young women who took HIV pre-exposure prophylaxis (PrEP) daily, levels of the PrEP drug…